Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and have experienced symptoms from it
- People whose heart specialist has determined that a procedure to isolate the pulmonary veins (the main electrical pathways involved in this type of irregular heartbeat) is appropriate for them, based on established medical guidelines
- People who are willing and able to undergo a second follow-up procedure scheduled 2 to 3 months after the first procedure
- People between the ages of 18 and 80 years old
- People who are willing and able to give their informed consent to participate
Who may not be able to join:
- People for whom an atrial fibrillation ablation procedure or blood-thinning medication is medically unsuitable for any known reason
- People who have previously had an ablation procedure or surgery on the upper chambers of the heart to treat an irregular heartbeat
- People whose irregular heartbeat is caused by a correctable or non-heart-related condition, such as a thyroid problem or an imbalance of minerals in the blood
- People with significant structural problems with their heart
- People with a history of a blood clotting or bleeding disorder
- People with severe kidney disease (confirm with trial site)
- People who have had a stroke or mini-stroke within the 3 months before enrolling in the trial
- People with an active infection anywhere in the body
- People who are pregnant, breastfeeding, or who are of childbearing age and are pregnant or planning to become pregnant during the study period
- People who are currently participating in another research study or registry that would interfere with this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sing-Chien Yap, MD, PhD, Erasmus Medical Center
Phone: +31650031551
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of pulmonary veins which shows reconnection during the repeat procedure 2-3 months after the index procedure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.